290 related articles for article (PubMed ID: 19085958)
1. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
Shalev I; Wong KM; Foerster K; Zhu Y; Chan C; Maknojia A; Zhang J; Ma XZ; Yang XC; Gao JF; Liu H; Selzner N; Clark DA; Adeyi O; Phillips MJ; Gorczynski RR; Grant D; McGilvray I; Levy G
Hepatology; 2009 Feb; 49(2):387-97. PubMed ID: 19085958
[TBL] [Abstract][Full Text] [Related]
2. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
Yang C; Chen Y; Guo G; Li H; Cao D; Xu H; Guo S; Fei L; Yan W; Ning Q; Zheng L; Wu Y
Gut; 2013 Aug; 62(8):1204-13. PubMed ID: 22637698
[TBL] [Abstract][Full Text] [Related]
3. C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.
Liu J; Tan Y; Zhang J; Zou L; Deng G; Xu X; Wang F; Ma Z; Zhang J; Zhao T; Liu Y; Li Y; Zhu B; Guo B
J Hepatol; 2015 Feb; 62(2):354-62. PubMed ID: 25200905
[TBL] [Abstract][Full Text] [Related]
4. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
Yu H; Liu Y; Wang H; Wan X; Huang J; Yan W; Xi D; Luo X; Shen G; Ning Q
Front Immunol; 2018; 9():2935. PubMed ID: 30619295
[No Abstract] [Full Text] [Related]
5. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
[TBL] [Abstract][Full Text] [Related]
6. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
Xu GL; Chen J; Yang F; Li GQ; Zheng LX; Wu YZ
Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
[TBL] [Abstract][Full Text] [Related]
7. A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2.
Wu D; Wang H; Yan W; Chen T; Wang M; Han M; Wu Z; Wang X; Ai G; Xi D; Shen G; Luo X; Ning Q
Immunol Res; 2016 Apr; 64(2):518-30. PubMed ID: 26482053
[TBL] [Abstract][Full Text] [Related]
8. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection.
Wijburg OL; Heemskerk MH; Sanders A; Boog CJ; Van Rooijen N
Immunology; 1996 Jan; 87(1):34-41. PubMed ID: 8666433
[TBL] [Abstract][Full Text] [Related]
9. IL-33 protects murine viral fulminant hepatitis by targeting coagulation hallmark protein FGL2/fibroleukin expression.
Yu H; Liu Y; Huang J; Wang H; Yan W; Xi D; Shen G; Luo X; Ning Q
Mol Immunol; 2017 Jul; 87():171-179. PubMed ID: 28494352
[TBL] [Abstract][Full Text] [Related]
10. [KCTD9, a novel potassium channel related gene, was highly expressed in hepatic NK cells and T cells of fulminant hepatitis mice induced by MHV-3].
Zhou YY; Zou Y; Chen T; Wang HW; Han MF; Pi B; Yan WM; Xi D; Huang JQ; Luo XP; Ning Q
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):833-7. PubMed ID: 22433305
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.
Zhu CL; Yan WM; Zhu F; Zhu YF; Xi D; Tian DY; Levy G; Luo XP; Ning Q
World J Gastroenterol; 2005 Nov; 11(44):6936-40. PubMed ID: 16437596
[TBL] [Abstract][Full Text] [Related]
12. Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection.
Ding JW; Ning Q; Liu MF; Lai A; Peltekian K; Fung L; Holloway C; Yeger H; Phillips MJ; Levy GA
Adv Exp Med Biol; 1998; 440():609-18. PubMed ID: 9782336
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
Wang J; Vuitton DA; Müller N; Hemphill A; Spiliotis M; Blagosklonov O; Grandgirard D; Leib SL; Shalev I; Levy G; Lu X; Lin R; Wen H; Gottstein B
PLoS Negl Trop Dis; 2015 May; 9(5):e0003755. PubMed ID: 25955764
[TBL] [Abstract][Full Text] [Related]
14. [The functions of liver natural killer cells in murine fulminant hepatitis induced by murine hepatitis virus strain 3].
Zou Y; Chen T; Wang HW; Yan WM; Luo XP; Ning Q
Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):660-4. PubMed ID: 18822205
[TBL] [Abstract][Full Text] [Related]
15. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.
Chung S; Gorczynski R; Cruz B; Fingerote R; Skamene E; Perlman S; Leibowitz J; Fung L; Flowers M; Levy G
Immunology; 1994 Nov; 83(3):353-61. PubMed ID: 7835959
[TBL] [Abstract][Full Text] [Related]
16. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.
Marsden PA; Ning Q; Fung LS; Luo X; Chen Y; Mendicino M; Ghanekar A; Scott JA; Miller T; Chan CW; Chan MW; He W; Gorczynski RM; Grant DR; Clark DA; Phillips MJ; Levy GA
J Clin Invest; 2003 Jul; 112(1):58-66. PubMed ID: 12840059
[TBL] [Abstract][Full Text] [Related]
17. [Role of CD4-CD8- T cells in the murine hepatitis virus type 3 induced chronic viral hepatitis].
Wang XJ; Yan WM; Zhang JG; Wang HW; Zou Y; Luo XP; Ning Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):180-3. PubMed ID: 19335979
[TBL] [Abstract][Full Text] [Related]
18. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Liu MF; Ning Q; Pope M; Mosmann T; Leibowitz J; Ding JW; Fung LS; Rotstein O; Gorczynski R; Levy GA
Adv Exp Med Biol; 1998; 440():415-23. PubMed ID: 9782309
[TBL] [Abstract][Full Text] [Related]
19. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.
Zhu C; Sun Y; Luo X; Yan W; Xi D; Ning Q
Hum Gene Ther; 2006 Jun; 17(6):589-600. PubMed ID: 16776568
[TBL] [Abstract][Full Text] [Related]
20. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
